Potentiation of the Anticancer Effects of Everolimus Using a Dual mTORC1/2 Inhibitor in Hepatocellular Carcinoma Cells
Oncotarget - United States
doi 10.18632/oncotarget.13808
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 7, 2016
Authors
Publisher
Impact Journals, LLC